Immune Related Adverse Events For Patients With Lung Cancer

Immune Related Adverse Events For Patients With Lung Cancer Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Immune Related Adverse Events For Patients With Lung Cancer book. This book definitely worth reading, it is an incredibly well-written.

Immune-Related Adverse Events for Patients with Lung Cancer

Author : Xuelei Ma,Hubing Shi,Benjamin Frey,Udo S. Gaipl
Publisher : Frontiers Media SA
Page : 180 pages
File Size : 52,8 Mb
Release : 2022-01-25
Category : Medical
ISBN : 9782889741717

Get Book

Immune-Related Adverse Events for Patients with Lung Cancer by Xuelei Ma,Hubing Shi,Benjamin Frey,Udo S. Gaipl Pdf

Fast Facts: Managing Immune-Related Adverse Events in Oncology

Author : Helen Westman,Malinda Itchins,Bernardo L. Rapoport
Publisher : Karger Medical and Scientific Publishers
Page : 142 pages
File Size : 42,5 Mb
Release : 2023-04-04
Category : Medical
ISBN : 9783318072716

Get Book

Fast Facts: Managing Immune-Related Adverse Events in Oncology by Helen Westman,Malinda Itchins,Bernardo L. Rapoport Pdf

Fast Facts: Managing Immune-Related Adverse Events in Oncology, 2nd edition, provides an overview of immuno-oncology and an update on immune checkpoint inhibitors and their associated toxicities, alongside the principles of diagnosing and managing immune-related adverse events, important nursing care considerations and a set of convenient management summaries for quick reference. As such, it is essential reading for all members of the cancer care team. Table of Contents: • Immunotherapy and its side effects: an overview • Gastrointestinal and hepatic adverse events • Dermatologic adverse events • Endocrine-related adverse events • Pulmonary adverse events • Less frequent adverse events • Optimizing patient care and early recognition of irAEs • Management summaries

Fast Facts: Managing immune-related Adverse Events in Oncology

Author : B.L. Rapoport,H. Westman
Publisher : Karger Medical and Scientific Publishers
Page : 106 pages
File Size : 55,7 Mb
Release : 2021-04-08
Category : Medical
ISBN : 9781912776405

Get Book

Fast Facts: Managing immune-related Adverse Events in Oncology by B.L. Rapoport,H. Westman Pdf

Immunotherapeutic products, and immune checkpoints inhibitors in particular, are increasingly used in the management of malignancies, both as monotherapies and in combination. Adverse events tend to be mild to moderate, but they can be severe or even life-threatening. Prompt recognition and effective management are vital. 'Fast Facts: Managing Immune-Related Adverse Events' is an accessible overview that brings together clear explanations and management summaries. This highly readable handbook examines the possible effects of immunotherapies on the skin, gastrointestinal tract, liver, endocrine system and lungs, as well as less frequent reactions. Detailed descriptions and evidence-based guidance for practical application make 'Fast Facts: Managing Immunotherapy-Related Adverse Events' an invaluable resource for all healthcare professionals who may encounter patients using immunotherapy, including nurses, who are particularly well placed to identify changes linked to use of immunotherapy, those working in the emergency department and primary care providers. Table of Contents: • Immunotherapy and its side effects: an overview • Gastrointestinal and hepatic adverse events • Dermatologic adverse • Endocrine-related adverse events • Pulmonary adverse events • Less frequent adverse events • Optimizing patient care and early recognition of immune-related adverse events • Management summaries

SITC’s Guide to Managing Immunotherapy Toxicity

Author : Marc S. Ernstoff, MD,Igor Puzanov, MD, MSCI, FACP,Caroline Robert, MD, PhD,Adi M. Diab, MD,Peter M. Hersey, MD, PhD
Publisher : Springer Publishing Company
Page : 250 pages
File Size : 42,6 Mb
Release : 2019-03-15
Category : Medical
ISBN : 9780826172150

Get Book

SITC’s Guide to Managing Immunotherapy Toxicity by Marc S. Ernstoff, MD,Igor Puzanov, MD, MSCI, FACP,Caroline Robert, MD, PhD,Adi M. Diab, MD,Peter M. Hersey, MD, PhD Pdf

The Society for Immunotherapy of Cancer's handbook,SITC’s Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers. With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care. Key Features: Outlines strategies for treating high-risk patients facing an acute or chronic side effect to immunotherapy Provides numerous tables that condense and highlight pertinent information for quick reference Describes the various clinical presentations and toxic reactions caused by immunotherapy Purchase includes access to the eBook for use on most mobile devices or computer

Multidisciplinary Management of Cancer Patients with Immune-Related Adverse Events from Checkpoint Inhibitors

Author : Mar Riveiro Barciela,Enriqueta Felip,Maria Suarez-Almazor
Publisher : Frontiers Media SA
Page : 93 pages
File Size : 45,6 Mb
Release : 2023-02-03
Category : Medical
ISBN : 9782832513682

Get Book

Multidisciplinary Management of Cancer Patients with Immune-Related Adverse Events from Checkpoint Inhibitors by Mar Riveiro Barciela,Enriqueta Felip,Maria Suarez-Almazor Pdf

Immunotherapy

Author : Aung Naing,Joud Hajjar
Publisher : Springer Nature
Page : 445 pages
File Size : 47,8 Mb
Release : 2022-01-01
Category : Medical
ISBN : 9783030793081

Get Book

Immunotherapy by Aung Naing,Joud Hajjar Pdf

The field of immuno-oncology continues to rapidly evolve as new insights to fight and treat cancer emerge. The fourth edition of Immunotherapy provides the most current overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. While immunotherapy has revolutionized the treatment landscape of several solid malignancies, several challenges still exist. Only a subset of patients derive clinical benefits; some do not respond at all, and others respond initially, only for their disease to progress later. Because these drugs can activate a broad range of immune cells, patients suffer from a unique set of side effects known as immune-related adverse events. As more immunotherapeutic agents are used in the clinic, it is important to provide updates about current and ongoing developments in the field to further research efforts and inform treatment decisions. The fourth edition will have a new focus on strategies to overcome the challenges associated with immunotherapy. Chapters will discuss topics such as biomarkers of response, resistance mechanisms, role of imaging in predicting immune-related adverse events, and management of immune-related adverse events. Written by leading experts conducting cutting-edge research, readers will gain up-to-date knowledge on the current state and future of immunotherapy.

Decoding Checkpoint Inhibitor-induced Immune-Related Adverse Events, volume II

Author : Deborah L. Burnett,Venessa Tsang,Megan Barnet,Roderick Clifton-Bligh,Katherine Samaras
Publisher : Frontiers Media SA
Page : 121 pages
File Size : 46,7 Mb
Release : 2023-11-14
Category : Medical
ISBN : 9782832538661

Get Book

Decoding Checkpoint Inhibitor-induced Immune-Related Adverse Events, volume II by Deborah L. Burnett,Venessa Tsang,Megan Barnet,Roderick Clifton-Bligh,Katherine Samaras Pdf

Immune Checkpoint Inhibitors in Cancer

Author : Fumito Ito,Marc Ernstoff
Publisher : Elsevier Health Sciences
Page : 400 pages
File Size : 43,5 Mb
Release : 2018-09-03
Category : Medical
ISBN : 9780323549509

Get Book

Immune Checkpoint Inhibitors in Cancer by Fumito Ito,Marc Ernstoff Pdf

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today’s available information on this timely topic into one convenient resource.

Drug-Induced Liver Injury

Author : Anonim
Publisher : Academic Press
Page : 288 pages
File Size : 40,9 Mb
Release : 2019-07-13
Category : Medical
ISBN : 9780128173176

Get Book

Drug-Induced Liver Injury by Anonim Pdf

Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. Includes the authority and expertise of leading contributors in pharmacology Presents the latest release in the Advances in Pharmacology series

Immunopharmacogenomics

Author : Yusuke Nakamura
Publisher : Springer
Page : 162 pages
File Size : 54,5 Mb
Release : 2015-09-18
Category : Medical
ISBN : 9784431557265

Get Book

Immunopharmacogenomics by Yusuke Nakamura Pdf

This book proposes immunogenomics, or immunopharmacogenomics, as the next-generation big science to uncover the role that the immune system plays in the pathogenesis of many diseases, by summarizing the importance of the deep sequencing of T-cell and B-cell receptors. Immunogenomics/immunopharmacogenomics, a genetic characterization of the immune system made possible by next-generation sequencing (NGS), will be important for the further understanding of the pathogenesis of various disease conditions. Abnormal immune responses in the body lead to development of autoimmune diseases and food allergies. Rejection of recipient cells and tissues, as well as severe immune reactions to donor cells, is also the result of uncontrolled immune responses in the recipient body. There have been many reports indicating that activated immune responses caused by the interaction of drugs and HLA are present in drug-induced skin hypersensitivity and liver toxicity. The importance of the host immune responses has been recognized in cancer treatments, not only for immunotherapy but also for cytotoxic agents and molecular targeted drugs. Hence, characterization of the T-cell receptor and B-cell receptor repertoire by means of NGS deep sequencing will ultimately make possible the identification of the molecular mechanisms that underlie various diseases and drug responses. In addition, this approach may contribute to the identification of antigens associated with the onset or progression of autoimmune diseases as well as food allergies. Although the germline alterations and somatic mutations have been extensively analyzed, changes or alterations of the immune responses during the course of various disease conditions or during various treatments have not been analyzed. It is also clear that computational analyses to draw meaningful inferences of functional recognition receptors on the immune cells remain a huge challenge.

Reducing Adverse Effects of Cancer Immunotherapy

Author : Daniele Maria-Ferreira,Cleber Machado-Souza,Elizabeth S. Fernandes
Publisher : Frontiers Media SA
Page : 136 pages
File Size : 43,5 Mb
Release : 2024-02-13
Category : Medical
ISBN : 9782832544662

Get Book

Reducing Adverse Effects of Cancer Immunotherapy by Daniele Maria-Ferreira,Cleber Machado-Souza,Elizabeth S. Fernandes Pdf

Chemotherapy and/or radiotherapy remain the main treatment options for most cancers. However, cancer treatment is associated with numerous adverse effects, including fatigue, stress, hair loss, pain, nausea, vomiting, anemia, altered immune system, oral and intestinal mucositis, which significantly affect patients' quality of life. In addition, the adverse effects may be associated with additional costs, morbidity, and mortality that affect various aspects of the patient's life, including physical health and emotional state. The management and reduction of adverse effects are extremely important and complex and are primarily aimed at providing comfort to the patient during chemotherapy treatment. In addition, it is important to note that in some cases, the severity of side effects associated with cancer treatment may result in the need to reduce the dose, which in turn may be associated with a reduction in the therapeutic efficacy. In view of this, the identification of new options aimed at alleviating the side effects and increasing the tolerability of chemotherapy is necessary to ensure the quality of life of cancer patients.

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice

Author : MiKaela M. Olsen,Kristine B. LeFebvre,Suzanne L. Walker,Elizabeth Prechtel Dunphy
Publisher : Unknown
Page : 0 pages
File Size : 41,9 Mb
Release : 2022
Category : Electronic
ISBN : 1635930553

Get Book

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice by MiKaela M. Olsen,Kristine B. LeFebvre,Suzanne L. Walker,Elizabeth Prechtel Dunphy Pdf

"Oncology nursing is a unique specialty that requires continuous learning to stay up to date on cancer pathophysiology, cutting-edge drugs, and the evidence-based management of cancer and cancer treatment-related toxicities. The Oncology Nursing Society's (ONS's) second edition of Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice provides nurses with the tools to understand how medications are used in cancer treatment, the effect of medication-related toxicities, and evidence-based recommendations to manage and treat these toxicities. This edition features many new cancer therapies approved since the 2019 publication. Each drug is categorized as chemotherapy, hormone, targeted, or immunotherapy agents. Extensive drug tables in the book provide nurses with tips for managing patients receiving these drugs. The expansion of oral antineoplastic therapies, alone or in combination with infusion therapy, requires that nurses review a patient's complete cancer treatment plan and consider the side effects, toxicities, and adherence to oral drugs to ensure patient tolerance and efficacy. This second edition has seen content expanded on the topic of genomics as we move forward in the world of personalized oncology. Health equity is approached with information discussing financial distress, cultural disparities, and health literacy. The latest guidelines and recommendations for treatment, symptom management, and survivorship have been integrated into this new text. This edition features a QR code, provided with the purchase of this book, to download quarterly drug updates. You will see new evidence related to many aspects of cancer nursing care incorporated into this edition, such as hypersensitivity response, safe handling of hazardous drugs, and more. The editors want to thank all of the contributors to this edition who worked tirelessly, despite a pandemic, to make this new edition a reality. This work builds on the knowledge of many generations of oncology nurses and has been used nationally and internationally to guide oncology nursing practice. We are proud to continue to serve oncology nurses worldwide with an essential resource to guide their practice"--

Chimeric Antigen Receptor T-Cell Therapies for Cancer E-Book

Author : Daniel W. Lee,Nirali N. Shah
Publisher : Elsevier Health Sciences
Page : 246 pages
File Size : 51,7 Mb
Release : 2019-11-30
Category : Medical
ISBN : 9780323755979

Get Book

Chimeric Antigen Receptor T-Cell Therapies for Cancer E-Book by Daniel W. Lee,Nirali N. Shah Pdf

From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area. Covers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care. Includes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care. Presents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon. Editors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy.

Evidence-based Advance and Management of Adverse Events of Immunotherapy for Cancer

Author : Yonggang Zhang,Xuelei Ma,Shuang Zhou
Publisher : Frontiers Media SA
Page : 207 pages
File Size : 44,5 Mb
Release : 2020-12-22
Category : Science
ISBN : 9782889662470

Get Book

Evidence-based Advance and Management of Adverse Events of Immunotherapy for Cancer by Yonggang Zhang,Xuelei Ma,Shuang Zhou Pdf

This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact.